BRUSSELS, Belgium, May 18, 2004 (PRIMEZONE) -- Recommended cash offer by UCB for CelltechIndepth interview available now on www.cantos.com with Georges Jacobs, Chairman of the Executive Committee, UCB
* Strategy and fit * Why Celltech? * Financing and integration
and Dr Roch Doliveux, CEO, UCB Pharma
* CDP 870 * Why Celltech? * Biotech v. pharma * Competing in the US * Integration
A video interview is also available with Dr Goran Ando, CEO, Celltech.
An on-demand webcast of the investor presentation will be available later today.
It's free to view. All you need to do is register at http://www.cantos.com
Cantos.com is an online financial website where top management of companies address the critical issues facing their businesses. All the interviews are available in video, audio and transcript.
If you would like to contact us, please email enquiries@cantos.com